SCHEMBL2679792

SCHEMBL2679792

NC(=O)c1cccc(C(F)(F)F)c1CN1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.48
PARP2 Q9UGN5 3/20 0.48
PARP3 Q9Y6F1 1/20 0.48
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
FAAH O00519 1/20 0.46
CYP2A13 Q16696 2/20 0.44
PIK3C2B O00750 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
AKR1C3 P42330 1/20 0.41
PIK3CD O00329 2/20 0.41
MTOR P42345 1/20 0.41
PIK3CG P48736 1/20 0.41
PIK3CB P42338 1/20 0.41
HIF1A Q16665 1/20 0.41
EPAS1 Q99814 1/20 0.41
SCN9A Q15858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28321312 0.88 KDM4E (0.46) PARP1PARP2PARP3ALDH1A1KDM4E
SCHEMBL4742353 0.85 PARP1 (0.44) PARP1PARP2PARP3ALDH1A1KDM4E
SCHEMBL20357333 0.85 CHRM3 (0.51) PARP1PARP2ALDH1A1KDM4E
SCHEMBL28847349 0.85 KDM4E (0.49) PARP1PARP2PARP3ALDH1A1KDM4E
SCHEMBL19760571 0.80 CYP2A13 (0.50) ALDH1A1KDM4ECYP2A13PIK3C2BMEN1
SCHEMBL4714644 0.77 FAAH (0.50) PARP1FAAHPIK3C2BAKR1C3PIK3CD
SCHEMBL16655571 0.77 ALDH1A1 (0.50) PARP1PARP2PARP3ALDH1A1KDM4E
SCHEMBL18040375 0.75 PARP1 (0.57) PARP1PARP2PARP3ALDH1A1KDM4E
SCHEMBL29832438 0.75 PDE3B (0.51) PARP1ALDH1A1KDM4ESCN9A
SCHEMBL19760570 0.74 KCNJ1 (0.46) ALDH1A1CYP2A13MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110291081-A BENZIMIDAZOLE COMPOUNDS AS C-KIT INHIBITORS 阿瑞雅德制药公司 2019-09-27 CN claimed
US-8426446-B2 Acrylamide derivative and use thereof in manufacture of medicament BEIJING SHIQIAO BIOPHARM CO. LTD. (CN) 2013-04-23 US disclosed
US-20120116075-A1 Acrylamide Derivative And Use Thereof In Manufacture Of Medicament BEIJING JIASHILIANBO PHARM SCI & TECH CO. LTD 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120116075-A1 Acrylamide Derivative And Use Thereof In Manufacture Of Medicament ABL1, ABL2, BCR PARP1 4101/4885PARP2 3393/4885PARP3 1922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.